A new report from manufacturers’ organisation, EEF, and business advisory firm, BDO, has highlighted that strong performance by the UK’s manufacturing sector may be masking future concerns around future investment and trade.
The pathway to value: walking in your customers’ shoes
David Southern, managing director, Spirit Access, discusses how a more patient-focused pathway to designing services is more likely the successful one and how companies can achieve this.
Here, in this online exclusive, Kalik looks at the need for a change in work culture and implementing new systems and procedures to make a more productive workplace.
Health research is thriving in the UK with more people taking part in NHS clinical research than ever before, new figures from the National Institute for Health Research (NIHR) show.
New research from The Center for Advancing Innovation (CAI) and PatSnap — a provider of R&D analytics — has revealed that the West is starting to lose its position as leaders in the Innovation Arms Race.
Here, we have a chat with Billy Amzal, PhD, X-Eng, MSc, MPA, who has been appointed as Certara’s senior vice president, decision and real-world data analytics.
Data and analytics company, GlobalData, has revealed that recent survey findings from the European Medicines Agency (EMA) into Brexit preparedness of the pharma industry support its own conclusions on the matter.
In this online opinion piece, Mark Davison, head of operations in the EU for rfxcel, outlines everything marketing authorisation holders (MAHs) need to know and what is needed for a seamless serialisation process
According to CPhI Korea, the Korean pharma market is experiencing significant growth in finished drug products, which is being attributed to an expanding domestic generics market.
In this online exclusive, Paul Brooks, executive director, Regulatory Affairs Professionals Society (RAPS), looks at the impact Brexit may have on the healthcare product regulatory space and how clarity is urgently needed.
After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will initially be seen in the healthcare supply chain
